Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
571 studies found for:    Open Studies | "Hematopoietic Stem Cells"
Show Display Options
Rank Status Study
21 Recruiting Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
Conditions: Primary Graft Failure;   Secondary Graft Failure
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Hematopoietic stem cell infusion
22 Not yet recruiting Modification of the Intestinal Microbiome by Diet Intervention to Mitigate Acute Graft-Versus-Host Disease
Condition: Hematopoietic Stem Cell Transplantation
Interventions: Dietary Supplement: Bob's Red Mill®;   Other: Standard BMT Diet
23 Recruiting Fitness in Allogeneic Stem Cell Transplantation
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Behavioral: Interval Exercise Training/Motivational Accelerometry
24 Recruiting Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Drug: post-transplantation cyclophosphamide
25 Recruiting Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
Condition: Hematopoietic Stem Cell Transplantation
Intervention: Device: CD3+ T cell depletion
26 Not yet recruiting Hematopoietic Stem Cell Microtransplantation for in AML
Condition: Acute Myeloid Leukemia
Interventions: Procedure: hematopoietic stem cell microtransplantation-long-term;   Procedure: hematopoietic stem cell microtransplantation-short-term;   Drug: Conditioning for CR group;   Drug: Conditioning for Non-CR group
27 Recruiting Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD
Condition: Genetic Rare Disease
Intervention: Drug: Busulfan
28 Recruiting Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
Conditions: Dyskeratosis Congenita;   Aplastic Anemia
Interventions: Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Stem Cell Transplant;   Drug: Anti-thymocyte globulin
29 Recruiting Hematopoietic Stem Cell Transplant in Devic's Disease
Condition: Devic's Disease
Intervention: Procedure: Hematopoietic stem cell transplantation
30 Recruiting Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation;   Myeloablative;   Delayed Platelet Engraftment
Intervention: Drug: Recombinant Human Thrombopoietin (rHTPO)
31 Not yet recruiting Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant (HSCT) For Lymphoma
Condition: Lymphoma
Interventions: Procedure: Allogeneic stem cell transplantation;   Drug: Fludarabine;   Drug: Thiotepa;   Drug: Methotrexate
32 Recruiting Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers
Conditions: Bone Marrow Transplantation;   Hematopoietic Stem Cells;   Multiple Myeloma;   Lymphoma
Interventions: Drug: Neupogen;   Procedure: Hyperbaric oxygen therapy;   Drug: Plerixafor
33 Recruiting MNGIE Allogeneic Hematopoietic Stem Cell Transplant Safety Study
Condition: Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
Intervention: Biological: Hematopoietic Allogeneic Stem Cells
34 Recruiting Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Conditions: Acute Leukemia;   Newly Diagnosed;   Relapsed
Intervention: Other: assessments
35 Recruiting Monitoring and Treatment of Relapsed Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation in Children
Condition: Leukemia
Interventions: Drug: Bortezomib;   Drug: Pravastatin
36 Recruiting Treosulfan Pharmacokinetics in Children Undergoing Allogeneic HSCT
Condition: Allogeneic Haematopoietic Stem Cell Transplantation
Intervention: Drug: Treosulfan
37 Recruiting Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Conditions: CMV Infection;   Persistent CMV Viremia
Intervention: Genetic: CMVpp65 Specific T-cells
38 Recruiting Tissue and Hematopoietic Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck Cancer
Conditions: Malignant Melanoma;   Head and Neck Cancer
Intervention: Drug: Filgrastim
39 Recruiting Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete Remission
Conditions: Acute Myeloid Leukemia;   Acute Lymphoid Leukemia
Interventions: Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: CXCR4 Antagonist;   Procedure: Hematopoietic Stem Cell Transplantation
40 Recruiting MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantation
Condition: Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Intervention: Drug: MLN9708

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.